Company Profile

Stereotaxis Inc
Profile last edited on: 12/14/2023      CAGE: 53QY8      UEI: DKCAD4U3W726

Business Identifier: Robotic cardiology instrument navigation systems: treatment enhancer for arrhythmias and coronary diseases.
Year Founded
1990
First Award
1992
Latest Award
1992
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

710 North Tucker Boulevard Suite 110
St. Louis, MO 63101
   (314) 678-6161
   info@stereotaxis.com
   www.stereotaxis.com
Location: Multiple
Congr. District: 01
County: St. Louis city

Public Profile

Stereotaxis is addressing making the treatment of complex cardiac arrhythmias more effective and safer through development of robotic cardiology instrument navigation systems, With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis enables physicians around the world to provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information. The firm's products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks worldwide. The firm also provides disposables and other accessories to include V-CAS catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. Stereotaxis, Inc. has alliances with Siemens AG Medical Solutions; Philips Medical Systems; and Biosense Webster, Inc.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
AMEX : STXS
IP Holdings
100-149

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1992 1 NIH $49,940
Project Title: Image guided magnetic stereotaxis

Key People / Management

  David Leo Fischel -- CEO & Chairman

  Keith Galloway

  Bevil J Hogg

  Michael P Kaminski -- President

  Michael A Lawson

  Robert McNeil -- Founder